TY - JOUR
T1 - Efficiency of the ligasure vessel sealing system for recipient hepatectomy in liver transplantation
AU - Lamattina, J. C.
AU - Hosseini, M.
AU - Fayek, S. A.
AU - Philosophe, B.
AU - Barth, R. N.
PY - 2013/6
Y1 - 2013/6
N2 - Background: Although the LigaSure device is widely used, its use in liver transplantation, where compounding factors of portal hypertension, coagulopathy, and thrombocytopenia exist, is poorly described. Methods: From October 1, 2011, to December 31, 2011, 6 patients underwent liver transplantation with recipient hepatectomy utilizing the LigaSure device. Outcomes using the device were compared with 6 contemporaneous patients in whom the device was not used. Results: Patient demographics, preoperative laboratory values, and Model for End-Stage Liver Disease scores were not different. Recipient hepatectomy was performed, on average, 43 minutes faster using the LigaSure device (P =.02). Although total operative time and intraoperative blood product usage were lower when the LigaSure was used, these differences did not attain statistical significance. Duration of stay and recipient readmission rates were similar. Conclusions: LigaSure vessel sealing is an efficient method for recipient hepatectomy in liver transplantation. Vessel sealing of caval, portal, and other structures can be safely performed in the setting of end-stage liver disease.
AB - Background: Although the LigaSure device is widely used, its use in liver transplantation, where compounding factors of portal hypertension, coagulopathy, and thrombocytopenia exist, is poorly described. Methods: From October 1, 2011, to December 31, 2011, 6 patients underwent liver transplantation with recipient hepatectomy utilizing the LigaSure device. Outcomes using the device were compared with 6 contemporaneous patients in whom the device was not used. Results: Patient demographics, preoperative laboratory values, and Model for End-Stage Liver Disease scores were not different. Recipient hepatectomy was performed, on average, 43 minutes faster using the LigaSure device (P =.02). Although total operative time and intraoperative blood product usage were lower when the LigaSure was used, these differences did not attain statistical significance. Duration of stay and recipient readmission rates were similar. Conclusions: LigaSure vessel sealing is an efficient method for recipient hepatectomy in liver transplantation. Vessel sealing of caval, portal, and other structures can be safely performed in the setting of end-stage liver disease.
UR - http://www.scopus.com/inward/record.url?scp=84879221189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879221189&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2012.11.022
DO - 10.1016/j.transproceed.2012.11.022
M3 - Article
C2 - 23769076
AN - SCOPUS:84879221189
SN - 0041-1345
VL - 45
SP - 1931
EP - 1933
JO - Transplantation proceedings
JF - Transplantation proceedings
IS - 5
ER -